[ad_1]
According to Reuters, the Moderna vaccine should provide immunity to the disease for at least one year after vaccination. This was announced at a press conference Monday by the manufacturer of the vaccine.
According to the manufacturer, they are convinced that the information RNA (mRNA) technology they use can thus protect against the new strain of COVID-19 coronavirus infection, which has been detected in some countries.
Vaccine for coronavirus
The company’s mRNA-1273 vaccine uses synthetic mRNA, which mimics the surface of a coronavirus and trains the immune system to recognize and neutralize the virus.
In December, Moderna promised to conduct studies to confirm the vaccine’s effectiveness against any strain of the virus.
On Monday, the company announced that it expects to deliver between 600 million in 2021. – 1 billion doses of vaccines. Vaccine-related sales are projected to reach $ 11.7 billion, according to preliminary agreements with the states. AMERICAN DOLLAR.
Saulius Čaplinskas
We recall that Professor Saulius Čaplinskas, a specialist in communicable diseases, wrote on the social network Facebook: “The concept of herd immunity was misunderstood. The likely scenario is that the coronavirus becomes another endemic virus that will continue to be a threat that will be reduced in the context of an effective global vaccination program. Even the existence of a highly effective vaccine does not guarantee the eradication of an infectious disease. “
The professor also added that “the effect of the vaccine will be gradual. The first goal of the vaccine is to protect vulnerable people, prevent symptomatic diseases, serious complications and deaths, and save lives. It is not yet clear whether the vaccines will prevent the transmission of the coronavirus and therefore reduce the number of infections.
There are reasons to believe that vaccinated people should take the same precautions. Therefore, the start of vaccination does not mean that it will be possible to give up physical isolation in the near future. “
It is strictly prohibited to use the information published by DELFI on other websites, in the media or elsewhere, or to distribute our material in any form without consent, and if consent has been obtained, it is necessary to cite DELFI as the source.
[ad_2]
